Clinical Trials on Rheumatoid Arthritis(RA)

Total 11470 results

AbbVie (prior sponsor, Abbott)

Completed

A Study in Rheumatoid Arthritis (RA) Patients to Compare Two Formulations of Adalimumab for Pharmacokinetic, Pharmacodynamic and Safety

Rheumatoid Arthritis

United States, Belgium, Czech Republic, Germany, Puerto Rico, Romania, Slovakia
Humanigen, Inc.

Terminated

Study of KB003 In Biologics-Inadequate Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Centocor, Inc.
Schering-Plough

Completed

An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy (GO-FORWARD)

Rheumatoid Arthritis

Australia, Poland, United States, Germany, Argentina, Canada, Korea, Republic of, Chile, New Zealand, Taiwan, Mexico, Hungary
Bristol-Myers Squibb

Completed

Pharmacokinetic Study to Compare the Blood Levels of Abatacept Manufactured at Lonza Biologics to the Blood Levels of Abatacept Manufactured at the Devens, Massachusetts (MA) Facility of Bristol-Myers Squibb

Rheumatoid Arthritis

United States
University of Sao Paulo

Unknown

Vascular Occlusion and Rheumatoid Arthritis

Rheumatoid Arthritis

Brazil
Pfizer

Completed

Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)

Rheumatoid Arthritis
Regeneron Pharmaceuticals
Sanofi

Completed

A Multiple-dose Study of the Safety and Tolerability of REGN88(SAR153191) in Rheumatoid Arthritis Subjects

Rheumatoid Arthritis

United States
AbbVie (prior sponsor, Abbott)

Completed

A 3-year Study Following up Patients With Moderate to Severe Rheumatoid Arthritis Treated With Humira in Greece

Rheumatoid Arthritis

Greece
Biogen

Withdrawn

BIIB057 in Subjects With Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs (EMBRACE)

Rheumatoid Arthritis

Canada
Biogen

Completed

BIIB023 (Anti-TWEAK) in Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

United States, Russian Federation
UCB Pharma

Completed

Efficacy and Safety of CDP870 Versus Placebo in the Treatment of the Signs and Symptoms of Rheumatoid Arthritis

Rheumatoid Arthritis
Pfizer

Completed

A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsA

Rheumatoid Arthritis

Korea, Republic of
Chugai Pharmaceutical

Completed

Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA012JP

Rheumatoid Arthritis
Chugai Pharmaceutical

Completed

Study of MRA in Patients With Rheumatoid Arthritis (RA)

Rheumatoid Arthritis
Human Genome Sciences Inc.

Terminated

A Continuation Trial for Subjects With Rheumatoid Arthritis That Have Completed Protocol LBRA01

Rheumatoid Arthritis

United States, Poland
Galapagos NV

Completed

Dose-ranging Study With GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients

Rheumatoid Arthritis

Hungary, Moldova, Republic of, Russian Federation, Ukraine
University Hospital, Rouen

Completed

Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid Arthritis

Rheumatoid Arthritis

France
Nichi-Iko Pharmaceutical Co., Ltd.

Completed

Study of NI-071 in Comparison With Remicade in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Amgen
Immunex Corporation

Completed

Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trial 016.0012

Rheumatoid Arthritis
Stanford University
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaborators

Completed

Initial Validation of PROMIS Physical Function/Disability Scales in Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

United States
Horizon Pharma Ireland, Ltd., Dublin Ireland

Completed

Study to Assess the Safety and Efficacy of Modified-Release Prednisone (Lodotra®) Therapy in Patients With Active Rheumatoid Arthritis (CAPRA-2)

Rheumatoid Arthritis

United States, Germany, Hungary, Canada, Poland, United Kingdom
Amgen

Completed

Treatment for Subjects With Active Rheumatoid Arthritis (RA)

Rheumatoid Arthritis
Pfizer

Completed

Study Comparing Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept

Rheumatoid Arthritis

France, Germany, Italy, Sweden, United Kingdom, Netherlands, Denmark, Finland, Norway
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Investigate How JNJ-39758979 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis Participants

Rheumatoid Arthritis

United States, Germany
Celltrion

Completed

Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA)

Rheumatoid Arthritis

Korea, Republic of
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy

Rheumatoid Arthritis
Pfizer

Completed

Co-Administration Of Methotrexate And CP-690,550

Rheumatoid Arthritis

United States
Pfizer

Completed

Current Adoption of Composite Indices in Evaluating Rheumatoid Arthritis Patients: An Observational Study (New Indices)

Rheumatoid Arthritis

Italy
TcLand Expression S.A.
Premier Research Group plc; Theradis pharma; Medpharmgene, Inc.

Terminated

Validation Study of RA-INF-Dx, a Multigene Molecular Test Used to Predict Non-Response to INfliximab Therapy (PRINT)

Rheumatoid Arthritis

Canada, France, Hungary, Italy, Lithuania, Romania, Slovakia, Spain
Pfizer

Completed

Effects Of CP-690,550 (Tasocitinib) On Cholesterol Metabolism In Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

United States, Hungary
Pfizer

Completed

A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Vertex Pharmaceuticals Incorporated

Completed

A 12-week Study of 4 Doses of VX-509 in Subjects With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Poland, Belgium, Romania, Serbia, United States, Puerto Rico, Germany, Hungary, Russian Federation, Croatia
Genentech, Inc.

Completed

A Study of the Effects of RoActemra/Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA)

Rheumatoid Arthritis

United States
Human Genome Sciences Inc., a GSK Company
GlaxoSmithKline

No longer available

Expanded Access Trial of Belimumab Antibody in RA Patients Who Were Previously Treated Under HGS Protocol LBRA99 (LBRA99)

Rheumatoid Arthritis

United States
Zalicus

Terminated

Long Term Safety Trial of z102 and Prednisone in Patients With Moderate to Severe Rheumatoid Arthritis

Rheumatoid Arthritis

Serbia
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Etanercept and Methotrexate vs. Methotrexate Alone in Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Abbott

Completed

Long Term Open Label Continuation Study

Rheumatoid Arthritis

United States, Canada
Galapagos NV

Completed

Safety and Preliminary Efficacy of GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients

Rheumatoid Arthritis

Moldova, Republic of
Otsuka Pharmaceutical Co., Ltd.
UCB Japan Co. Ltd.

Completed

Efficacy Confirmation Trial of CDP870 Without Coadministration of Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

Japan
Novartis

Completed

Safety and Efficacy of ACZ885 in Adult Patients With Established Rheumatoid Arthritis

Rheumatoid Arthritis

Russian Federation, Spain, Turkey, Switzerland
Lexicon Pharmaceuticals

Completed

A Study to Determine the Safety and Efficacy of LX3305 in Subjects With Active Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Chugai Pharmaceutical

Completed

A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.)

Rheumatoid Arthritis

Japan
Novartis

Completed

Safety and Efficacy of Intravenous ACZ885 and Oral Methotrexate Therapy in Patients With Early Rheumatoid Arthritis

Rheumatoid Arthritis

Spain, Germany, Belgium, Italy, Netherlands, United States
Daewoong Pharmaceutical Co. LTD.

Unknown

Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male Volunteers

Rheumatoid Arthritis

Korea, Republic of
Shanxi Medical University

Unknown

Disease-Modifying Antirheumatic Drugs Cycle Combination Therapy Research (DCCT)

Rheumatoid Arthritis

China
Bristol-Myers Squibb

Completed

Abatacept With Methotrexate- Phase IIB

Rheumatoid Arthritis

Belgium, United States, Canada, Germany, United Kingdom, Australia, France, Ireland, Netherlands, Argentina, South Africa
Genentech, Inc.

Terminated

A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MTRX1011A in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis
Biotie Therapies Corp.

Completed

BTT-1023 in Rheumatoid Arthritis

Rheumatoid Arthritis

Bulgaria
Abbott

Terminated

Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or Etanercept to Adalimumab in Patients With Active Rheumatoid Arthritis (RA). A Multicenter Post-Marketing Observational Study in Routine Clinical Use (FALLA)

Rheumatoid Arthritis

Mexico
UCB Pharma

Completed

Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study (CERTAIN)

Rheumatoid Arthritis

France, Poland, Germany, Austria, Italy

3

Subscribe